IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Celyad Oncology SA

CUSIP: 151205200 | 47 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

Rhumbline Advisers9,000
0.0% of portfolio›$5.9K
StyleTurnoverLocationFiled
Rhumbline Advisers
9,000$5.9K0.0%IndexVery LowBoston, MA2023-11-09